Scadenza: 13 May 2022
Topic:
The aim of this call is to fund groundbraking translational research on malignant lymphoma, malignant lymphoid neoplasia and related malignant blood diseases (particularly lymphoid disorders). Projects will be considered eligible that enhance our understanding and furnish insights or develop tools that will advance the treatment.
Ente finanziatore:
Lymph&Co
Duration of the project: maximum 4 years
Who can participate:
The main applicant must be employed by a university, university hospital or research organization.
Partnership: Not Mandatory
Status:
Closed
Quota finanziabile:
Max € 1,5 milion
Topic:
The aim of this call is to fund groundbraking translational research on malignant lymphoma, malignant lymphoid neoplasia and related malignant blood diseases (particularly lymphoid disorders). Projects will be considered eligible that enhance our understanding and furnish insights or develop tools that will advance the treatment.
Who can participate:
The main applicant must be employed by a university, university hospital or research organization.
Programme:
Consortium: Not required
Status: Open
Total budget:
Funding rate:
Max € 1,5 milion
